Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067650
Filing Date
2017-12-29
Accepted
2017-12-29 17:02:16
Documents
2
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2248
2 POA DOCUMENT poa.txt EX-24.3_758899 3554
  Complete submission text file 0001209191-17-067650.txt   7532
Mailing Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583
Business Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583 855 855 GALE
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELLAS LIFE SCIENCES GROUP, INC. 2000 CROW CANYON PLACE, STE. 380 SAN RAMON CA 94583
Business Address
Sarlis Nicholas J. (Reporting) CIK: 0001724151 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33958 | Film No.: 171282547